These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39261513)

  • 1. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Sritara P; Phrommintikul A;
    Sci Rep; 2024 Sep; 14(1):21264. PubMed ID: 39261513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
    Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
    Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
    Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
    Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Tang WH; Wang Z; Li XS; Fan Y; Li DS; Wu Y; Hazen SL
    Clin Chem; 2017 Jan; 63(1):297-306. PubMed ID: 27864387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
    Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
    Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
    J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
    Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
    Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
    Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
    Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
    Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
    Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
    J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
    J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
    Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.